Literature DB >> 12089527

Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.

Claudia A L Ruivenkamp1, Tom van Wezel, Carlo Zanon, Alphons P M Stassen, Cestmir Vlcek, Tamás Csikós, Anita M Klous, Nikos Tripodis, Anastassis Perrakis, Lucie Boerrigter, Peter C Groot, Jan Lindeman, Wolter J Mooi, Gerrit A Meijjer, Gert Scholten, Hans Dauwerse, Vaclav Paces, Nico van Zandwijk, Gert Jan B van Ommen, Peter Demant.   

Abstract

Only a small proportion of cancers result from familial cancer syndromes with Mendelian inheritance. Nonfamilial, 'sporadic' cancers, which represent most cancer cases, also have a significant hereditary component, but the genes involved have low penetrance and are extremely difficult to detect. Therefore, mapping and cloning of quantitative trait loci (QTLs) for cancer susceptibility in animals could help identify homologous genes in humans. Several cancer-susceptibility QTLs have been mapped in mice and rats, but none have been cloned so far. Here we report the positional cloning of the mouse gene Scc1 (Susceptibility to colon cancer 1) and the identification of Ptprj, encoding a receptor-type protein tyrosine phosphatase, as the underlying gene. In human colon, lung and breast cancers, we show frequent deletion of PTPRJ, allelic imbalance in loss of heterozygosity (LOH) and missense mutations. Our data suggest that PTPRJ is relevant to the development of several different human cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089527     DOI: 10.1038/ng903

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  82 in total

1.  Lessons from a decade of integrating cancer copy number alterations with gene expression profiles.

Authors:  Norman Huang; Parantu K Shah; Cheng Li
Journal:  Brief Bioinform       Date:  2011-09-23       Impact factor: 11.622

2.  Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase.

Authors:  Keiko Takahashi; Raymond L Mernaugh; David B Friedman; Rebecca Weller; Nobuo Tsuboi; Hironobu Yamashita; Vito Quaranta; Takamune Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 3.  Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer.

Authors:  Lakshmi Reddy Bollu; Abhijit Mazumdar; Michelle I Savage; Powel H Brown
Journal:  Clin Cancer Res       Date:  2017-01-13       Impact factor: 12.531

4.  Crystallization and preliminary X-ray diffraction analysis of rat protein tyrosine phosphatase eta.

Authors:  Huita C Matozo; Alessandro S Nascimento; Maria A M Santos; Rodolfo Iuliano; Alfredo Fusco; Igor Polikarpov
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-26

Review 5.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

6.  Low-resolution structure and fluorescence anisotropy analysis of protein tyrosine phosphatase eta catalytic domain.

Authors:  Huita C Matozo; Maria A M Santos; Mario de Oliveira Neto; Lucas Bleicher; Luís Mauricio T R Lima; Rodolfo Iuliano; Alfredo Fusco; Igor Polikarpov
Journal:  Biophys J       Date:  2007-03-30       Impact factor: 4.033

7.  Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk.

Authors:  Karlyne M Reilly
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

8.  MicroRNA genes are frequently located near mouse cancer susceptibility loci.

Authors:  Cinzia Sevignani; George A Calin; Stephanie C Nnadi; Masayoshi Shimizu; Ramana V Davuluri; Terry Hyslop; Peter Demant; Carlo M Croce; Linda D Siracusa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

9.  G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.

Authors:  Gilles Doumont; Alain Martoriati; Chantal Beekman; Sven Bogaerts; Patrick J Mee; Fabrice Bureau; Emanuela Colombo; Myriam Alcalay; Eric Bellefroid; Francesco Marchesi; Eugenio Scanziani; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

Review 10.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.